Skip to main content
logo
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.30
+0.75 (7.11%)
At close: May 13, 2026, 4:00 PM EDT
11.30
0.00 (0.00%)
After-hours: May 13, 2026, 4:00 PM EDT

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2081425680--
Market Cap Growth
162.41%151.89%-29.77%---
Enterprise Value
205.43136.6363.7773.2100
Last Close Price
11.307.965.108.34--
PE Ratio
--3.09-1.20-1.20--
PB Ratio
-86.61-4.977.04--
P/TBV Ratio
-130.6874.51-5.503.71--
P/FCF Ratio
--3.83-1.51-2.44--
P/OCF Ratio
--3.83-1.52-2.45--
EV/EBITDA Ratio
--3.73-1.46-2.12--
EV/EBIT Ratio
--3.62-1.42-2.05--
EV/FCF Ratio
--3.70-1.72-2.23--
Debt / Equity Ratio
-9.258.25-2.220.530.760.04
Debt / EBITDA Ratio
-0.39-0.40-0.59-0.20-0.33-0.11
Debt / FCF Ratio
-0.37-0.39-0.70-0.21-0.33-0.08
Net Debt / Equity Ratio
0.42-2.48-0.74-0.53-0.01-1.03
Net Debt / EBITDA Ratio
0.020.11-0.190.17-0.062.19
Net Debt / FCF Ratio
0.020.11-0.230.18-0.061.59
Asset Turnover
-00000.39
Quick Ratio
2.072.291.531.320.907.93
Current Ratio
2.242.381.801.681.568.08
Return on Equity (ROE)
-40386.90%817.92%-170157.00%-346.95%-62.39%1220.60%
Return on Assets (ROA)
-154.81%-139.58%-162.63%-143.52%-39.83%-54.65%
Return on Invested Capital (ROIC)
-4285.06%-5771.08%-1243.91%-399.52%-409.33%-24188.90%
Return on Capital Employed (ROCE)
-226.30%-219.22%-264.27%-215.42%-46.99%-313.02%
Earnings Yield
-19.50%-32.41%-83.33%-83.45%--
FCF Yield
-18.68%-26.09%-66.05%-40.90%--
Buyback Yield / Dilution
-29.18%-25.48%-141.35%-242.51%0.00%0.00%
Total Shareholder Return
-29.18%-25.48%-141.35%-242.51%0.00%0.00%
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q